Laura Mcentee
Liverpool, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosis.
Journal: The Journal of antimicrobial chemotherapy
Published: May 13, 2025
BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections.
Journal: Nature communications
Published: December 18, 2023
Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance.
Journal: Antimicrobial agents and chemotherapy
Published: March 22, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.
Journal: The Journal of antimicrobial chemotherapy
Published: December 21, 2021
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
Journal: The Journal of antimicrobial chemotherapy
Published: September 01, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.
Journal: Antimicrobial agents and chemotherapy
Published: May 11, 2021
Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae.
Journal: Antimicrobial agents and chemotherapy
Published: May 27, 2020
Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae.
Journal: Antimicrobial agents and chemotherapy
Published: January 28, 2020
Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
Journal: mBio
Published: December 05, 2019
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.
Journal: Antimicrobial agents and chemotherapy
Published: March 22, 2019
Last Updated: 09/26/2026